scorpion
- 13 Aug 2003 13:54
Bioprogress is a stock I have been in and out of quite a few times since it floated in May but not much mention here on the Investors' Room. Does anyone else follow this stock. I see it is up 1.5p today and a few good buyers seem to have appeared.
Scripophilist
- 26 Feb 2004 10:36
- 196 of 2372
Bullie, I had a buy order on a 110p but it never got filled and then I had to take the kids to school so missed out, such is life.
Bullshare
- 26 Feb 2004 10:44
- 197 of 2372
Dil; Too right, which means you should be well out of the market u sad old git:-). You are getting just like the old sage Martini.
Scrip> Wise words indeed. But instead of 'There in lies a lot of the skill.' you could have said 'there is a lot of skill in lies':-)
Bones
- 26 Feb 2004 10:51
- 198 of 2372
So Dil, given the potential, when are you adding this to your pension fund? The trend is clearly up and I know it is annoying to have missed paying the sub-70p price that was available only last month but investors and traders shouldn't be swayed by emotion....:)
ssmush
- 26 Feb 2004 11:09
- 199 of 2372
Scrip,
pls explain ur remark re- "lack of news is deliberate" when u had just agreed with dil re- leakiness!!
Thanks
ssm
Dil
- 26 Feb 2004 11:20
- 200 of 2372
Bones , read the traders thread across the road :-)
Gianni
- 26 Feb 2004 11:48
- 201 of 2372
Seems that when it comes to some shares then charts, following rsl's, not getting attached to a share, etc., all go out the window. Potential is just that - what's the patent position? (can it be got round/duplicated easily?) - anyone know what the Japanese are up to? What if BPRG lose their patent lawsuit against Stanelco + what will it cost even if they win?
Fundamentals? Better by miles than PDX and even PRM but can someone explain that if the TOTAL revenues by the FMC deal = 86m, = 14m per year with a generous net 20% profit margin = 2.8m profit PA justify a 120m+ cap. In 6 years their patent will have long gone/been got round. More deals - assume they double the above - 10 bagger from 1.20 - I don't think so - best they can hope for is 2 imo with a new big deal. Forget the hype - look at the facts and wait for the deal. Mind you that won't stop the punters piling in but as I always say wtfdik.
Mind you I'm just jealous of these guys that got in at 40-50 and I missed it :)
Bones
- 26 Feb 2004 12:18
- 202 of 2372
Gianni - you may be right to question 2+ this year and justify it. Even the long term die-hards over the road have never said it is a ten bagger in one year but over several. What they do argue though is that the product is one that appears to have the lead in its industry and "could" become an industry standard.
Certainly, its water-soluble film for pills is flexible, can be mass-produced with the company logo on each pill (preventing counterfeiting), can be made faster than today's methods, are gelatin-free, can control rate of absorption in the body, can carry more than one drug in a pill and be released at different times, etc etc. There are 4 separate technologies and FMC have collared one of them only. The OTC deal to come covers another one for the USA and EU. So plenty left to licence. They also have the ostomy deal with Bristol Myers Squibb already signed and likely to start producing royalties this year.
The very optimistic say that this scenario is Microsoft-like. So, yes, there is huge potential but many challenges lie ahead. However, the acceptance by FMC and others after much due diligence is an enormous vote of confidence and a re-rating was justified. The question is how do you value such potential? Opinions on "gone too far" or "in the price" are difficult to substantiate one way or the other.
Even so, if the price does fly this year, I will certainly take profits along the way.
beaufort1
- 26 Feb 2004 12:24
- 203 of 2372
This one's up and down like a whore's drawers today.
Gianni
- 26 Feb 2004 12:26
- 204 of 2372
Bones - excellent post - that is the kind or reply I was looking for.
Bullshare
- 26 Feb 2004 12:27
- 205 of 2372
Well bless my cotton socks, BPRG now + for the day and currently 130/133. too tempting so selling this a.m's buy for +22p and yesterdays for +4p.Yum. Got lots still held. Off to lunch.
Dil
- 26 Feb 2004 13:22
- 206 of 2372
Only got +13 for mine , maybe I should get up earlier.
Scripophilist
- 26 Feb 2004 14:45
- 207 of 2372
If you are in it for the day, I woudl be tempted to cash out now with the weak start on wall street.
jays
- 26 Feb 2004 15:07
- 208 of 2372
Nice post bones.
Have been in this stock many years, had some worries but have done much research on this. BPRG has some seriously good patents and some very determined people.
Dil
- 26 Feb 2004 15:18
- 209 of 2372
If it fails at 140p then we could get a lower low , jury is out at the moment.
Scripophilist
- 26 Feb 2004 16:26
- 210 of 2372
Looks like a surge of late buyers.
goldfinger
- 27 Feb 2004 01:29
- 211 of 2372
Sell, wouldnt dream of it if the news I got through just now is correct and it was last time three days before the last contract annoucement. Mind it aint over until the fat lady sings. Things can go wrong at the last minute.
The news will come from across the pond. Cant say anymore. Yearly results in about a weeks time.
cheers GF.
Dil
- 27 Feb 2004 09:24
- 212 of 2372
Leaky , leaky ..... good luck all.
ssanebs
- 27 Feb 2004 11:51
- 213 of 2372
a placing being announced with the deal to fund a film factory in the us @ 100p
Janus
- 27 Feb 2004 13:02
- 214 of 2372
Bioprogress plans placing at 100p
Tim Freeborn
Announcement likely next week; placing at very deep discount
BioProgress Technology Internatinal(BPRG), the current punters favourite, is planning a placing next week at 100p. One investor was told he had to pay by next Wednesday.
In December the company raised 7m at 50p to fund the building of a factory to make its patented Xgel film.
The new placing is likely to coincide with a deal with a US maker of non-prescription medicines. This was promised by the end of January but has apparently been delayed because BioProgress concentrated on the link-up with FMC Biopolymer which was announced on 4 February and sent the shares soaring.
BioProgress has made a habit of raising money at a deep discount. It was floated early last year at 14p, around a third below its price on the Nasdaq OTC market. The December placing was also a third below its then price.
Late morning Bioprogress shares were down 2.1% to 135p. The company plans to post its preliminary results for the trading period from 22 May 2003 to 31 December 2003 on Monday 8 March.
http://www.moneyam.com/action/news/showArticle?id=308938
RobinReeve
- 27 Feb 2004 13:59
- 215 of 2372
How do we get our hands on these at 1 .... ?